| 000 | 01580 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516081757.0 | ||
| 264 | 0 | _c20120808 | |
| 008 | 201208s 0 0 eng d | ||
| 022 | _a1873-5576 | ||
| 024 | 7 |
_a10.2174/156800912800190929 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBagnasco, L | |
| 245 | 0 | 0 |
_aRole of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors. _h[electronic resource] |
| 260 |
_bCurrent cancer drug targets _cMay 2012 |
||
| 300 |
_a303-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAdenomatous Polyposis Coli _xdrug therapy |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBevacizumab |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
| 700 | 1 | _aPiras, D | |
| 700 | 1 | _aParodi, S | |
| 700 | 1 | _aBauer, I | |
| 700 | 1 | _aZoppoli, G | |
| 700 | 1 | _aPatrone, F | |
| 700 | 1 | _aBallestrero, A | |
| 773 | 0 |
_tCurrent cancer drug targets _gvol. 12 _gno. 4 _gp. 303-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/156800912800190929 _zAvailable from publisher's website |
| 999 |
_c21592487 _d21592487 |
||